Nuveen’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.75M Buy
96,786
+2,200
+2% +$41.9K ﹤0.01% 2324
2025
Q4
$2.06M Sell
94,586
-1,300
-1% -$37.2K ﹤0.01% 2280
2025
Q3
$3.13M Sell
95,886
-20,100
-17% -$742K ﹤0.01% 2122
2025
Q2
$4.12M Sell
115,986
-54,200
-32% -$1.76M ﹤0.01% 1974
2025
Q1
$5.77M Buy
170,186
+59,600
+54% +$2.14M ﹤0.01% 1842
2024
Q4
$3.6M Buy
110,586
+5,700
+5% +$236K ﹤0.01% 2126
2024
Q3
$5.11M Buy
104,886
+4,300
+4% +$229K ﹤0.01% 1978
2024
Q2
$4.45M Sell
100,586
-1,500
-1% -$69.2K ﹤0.01% 2011
2024
Q1
$5.73M Sell
102,086
-56,485
-36% -$3.41M ﹤0.01% 1919
2023
Q4
$9.54M Buy
158,571
+19,600
+14% +$1.24M ﹤0.01% 1606
2023
Q3
$9.33M Buy
138,971
+21,666
+18% +$1.5M ﹤0.01% 1519
2023
Q2
$8.1M Sell
117,305
-766
-0.6% -$50.1K ﹤0.01% 1638
2023
Q1
$5.69M Buy
118,071
+16,500
+16% +$807K ﹤0.01% 1814
2022
Q4
$5.07M Sell
101,571
-1,700
-2% -$82.4K ﹤0.01% 1895
2022
Q3
$4.21M Buy
103,271
+6,700
+7% +$314K ﹤0.01% 2001
2022
Q2
$5.31M Sell
96,571
-7,249
-7% -$306K ﹤0.01% 1900
2022
Q1
$3.77M Buy
103,820
+10,600
+11% +$419K ﹤0.01% 2206
2021
Q4
$4.34M Buy
+93,220
New +$4.73M ﹤0.01% 2205

Other funds holding LEGN

Nuveen's LEGN Position: Q1 2026 in Review

Nuveen increased its Legend Biotech (LEGN) stake by 2.3% in Q1 2026, buying an estimated $41.9K and bringing the position to 96,786 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2324.

Nuveen first reported a position in LEGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $9.54M in Q4 2023. 191 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Nuveen held 96,786 shares of Legend Biotech worth $1.75M as of Q1 2026.
  • Nuveen bought 2,200 Legend Biotech shares in Q1 2026, an estimated $41.9K.
  • Legend Biotech made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2324 holding.
  • Nuveen first reported a position in Legend Biotech in Q4 2021 and has held it in 18 quarters since.
  • Nuveen's Legend Biotech position peaked at $9.54M in Q4 2023.
  • 191 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.